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Abstract
Interactions between modular domains and short linear motifs (3–10 amino acids peptide stretches) are crucial for cell
signaling. The motifs typically reside in the disordered regions of the proteome and the interactions are often transient,
allowing for rapid changes in response to changing stimuli. The properties that make domain-motif interactions suitable
for cell signaling also make them difficult to capture experimentally and they are therefore largely underrepresented
in the known protein-protein interaction networks. Most of the knowledge on domain-motif interactions is derived
from low-throughput studies, although there exist dedicated high-throughput methods for the identification of
domain-motif interactions. The methods include arrays of peptides or proteins, display of peptides on phage or yeast,
and yeast-two-hybrid experiments. We here provide a survey of scalable methods for domain-motif interaction profiling.
These methods have frequently been applied to a limited number of ubiquitous domain families. It is now time to
apply them to a broader set of peptide binding proteins, to provide a comprehensive picture of the linear motifs in the
human proteome and to link them to their potential binding partners. Despite the plethora of methods, it is still a
challenge for most approaches to identify interactions that rely on post-translational modification or context dependent
or conditional interactions, suggesting directions for further method development.
Keywords: Linear motif, Protein-protein interactions, Phage display, Yeast-surface display, Peptide arrays, Interaction
profiling
Introduction
The size of the human interactome has been estimated
to 650,000 interactions [1]. The known interactome is
rapidly growing through the efforts of various high-
through put studies such as affinity-purification coupled
to mass spectrometry (AP-MS) [2] and yeast-two-hybrid
(Y2H) [3]. However, less than 20 % of potential pairwise
human protein-protein interactions have been explored
through high-throughput studies [4]. About 15–40 % of
the protein-protein interactions involve the recognition of a
peptide motif (3–10 amino acid stretches) by a globular
protein [5]. These interactions have crucial roles in defining
cellular functions, being involved in processes such as
protein scaffolding, cell signaling, targeting to subcellular
compartments and post-translational modifications (PTMs)
[6]. In parity with the large number of proposed interac-
tions, a recent estimate suggested that the human proteome
holds over 100,000 binding motifs [7]. The motifs are typic-
ally found in disordered regions or in exposed flexible loops
and bind their target proteins through transient interactions
with affinities in the low- to mid-micromolar range [8, 9].
A recent analysis revealed that 22 % of human disease mu-
tations occur in the unstructured regions, and suggested
that disease mutations in motifs are neglected players in
cancer [10]. It is thus of crucial importance to systematic-
ally identify linear motifs in the proteome and link the mo-
tifs to the domains that recognize them.
A growing number of domains have been found to en-
gage in peptide-mediated interactions. Today, there are
about 200 known peptide binding domain families [11]
with well studied examples being the PDZ (postsynaptic
density protein 95/discs large/zona occludens 1) domains
that typically bind to C-terminal peptides of target pro-
teins [12–14], the poly proline binding WW domains [15]
and SH3 (Src Homology 3) domains [16, 17], and the
phosphotyrosine binding SH2 (Src Homology 2) domains* Correspondence: Ylva.ivarsson@kemi.uu.se
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[18–22] (Table 1). Manually curated databases such as
the eukaryotic linear motif (ELM) resource [23] and the
Linear Motif mediated Protein interaction Database
(LMPID) [24] contain over 2,000 annotated instances
of domain-motif interactions, most of which have been
discovered by low-throughput experiments such as pull-
downs, co-immunoprecipitation (co-IPs), mutational ana-
lysis and detailed structural studies of domain-peptide
complexes. There is thus a striking discrepancy between
the estimated number of motif-based interactions and the
experimentally validated cases, suggesting that a vast num-
ber of motifs and binding domains are to be discovered.
However, domain-motif interactions are difficult to cap-
ture due to their limited binding interfaces [8]. They have
therefore commonly been overlooked in the methods such
high-throughput AP-MS or Y2H. Indeed, an analysis of
Y2H data revealed that only 1 % of the interactions rely on
interactions with linear motifs [5]. The interactions can
however be captured through AP-MS by the use of cross-
linking [25] or by a recently developed proximity biotinyl-
ation approach [26, 27]. Although these methods may
capture transient interactions, they will not necessarily
report on binary interactions and they provide no dir-
ect information on the motifs that are involved in the
interactions.
There is a variety of experimental methods dedicated to
the characterization of peptide binding modules and the
identification of peptide binding motifs [28]. The methods
essentially fall into three main categories: arrays, display
methods and protein-fragment complementation assays.
Here, we summarize these methods for the identification
of motif-based interactions (Fig. 1, Table 2); we introduce
the basic principle of the methods and highlight recent ad-




Peptide arrays rely on the chemically synthesis of pep-
tides with known sequences on a solid support such as a
cellulose membrane or a glass slide [29–32]. The micro-
array is thereafter incubated with the target protein and
the bound protein is detected using for example specific
antibodies or fluorescent or radioactive labeled proteins
(Fig. 1a). Peptide arrays are typically semi-quantitative
and allow the comparison of affinities between ligands
immobilized on the same slide. An advantage of peptide
array over display methods is that the peptide sequences
are known and that the sequences can be systematically
varied to map binding motifs. The method also provides
information on non-binding peptides. A drawback of the
method is a high number of false positive and false nega-
tive read-outs. This is partly due to the fact that the yield
and purity of the peptides are difficult to evaluate and
can vary between peptides on the same chip.
Peptide arrays were first introduced in the early nine-
teen’s when two groups reported techniques for parallel
chemical synthesis of peptides on solid support. Fodor and
co-workers described a light-directed, spatially addressable
parallel chemical synthesis [33] and Frank introduced the
SPOT-synthesis [34]. The majority of peptide arrays re-
ported to date have relied on the SPOT-synthesis,
which is commercially available and can be performed
fully automated. Peptides are typically synthesized with
a free N-terminal sequence. However, SPOT arrays have
been further adapted for the synthesis of peptides with
free C-terminal sequences, which was crucial for prob-
ing the binding specificities of, for example, PDZ do-
mains [35].
A main advantage of peptide arrays is the possibility
to incorporate modified and non-natural amino acids.
This allow for direct and controlled mapping of interac-
tions regulated by PTMs, such as phosphorylation [21]
and acetylation [36]. For example, the tyrosine phospho-
peptide binding of SH2 domains have been elucidated
using a quantitative peptide microarray based approach
[18] and by the use of a high-density peptide
chip technology [21]. Similarly, Filippakopolous and
co-workers created SPOT arrays that covered all
possible sites for ε-N-acetylation of lysine residues of
human histones [36]. These arrays were screened
against 43 members of the bromodomain family.
Affinities were determined by isothermal titration
calorimetry (ITC) and a comprehensive structural
characterization was performed. The study suggested
Table 1 Examples of interactions between modular domains and linear motifs
Protein Domain Consensus motif Target protein/binding peptide Function Reference
GRB2 SH2 pY-x-(E/N) ERBB3/pYMN Ras signaling [93]
GRB2 SH3 P-x-x-P-x-(R/K) SOS1/PPVPPR Ras signaling [94]
SUMO1 SUMO (V/I/L)-(V/I/L)-(D/E)-(V/I/L) PIAS1/VIDL Sumoylation [66]
SDCBP PDZ Φ-x-Φ-coo- SDC1/EFYA-coo- Trafficking [95]
YAP1 WW PP-x-Y TP73/PPPY Transcriptional regulation [96]
“Φ” indicates a hydrophic residue and “x” any amino acid
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that bromodomains recognize a combination of PTMs
rather than single acetylates sequences.
Traditionally the throughput of peptide microarrays
has been up to a few thousand peptides per chip. Ultra-
dense peptide arrays now allow array sizes of 105–106
peptides [37–39]. These ultra-dense peptide arrays have
been used for epitope mapping of antibodies. For ex-
ample, Uhlen and co-workers developed a proteome
wide peptide array, which was used for epitope mapping
and cross-reactivity analysis of antibodies [38]. Using a
photolithic technique they were able to in situ synthesize














Fig. 1 Schematic representation of discussed techniques for the identification of motif-based interactions. Orange represents target protein; blue
hexagon represents a binding motif; yellow, green and purple represent non-binding sequences peptides. Pink star represent a detection signal
e.g. fluorescence. a Peptide microarray: Peptides with known sequences are synthesized on a solid support, incubated with the target protein and
interactions are detected with specific antibodies or labeled target protein. b Protein array: A selection of different purified proteins are spotted
on a solid support and incubated with a labeled peptide. c Peptide phage-display: Bait protein is immobilized and used in selections against a
peptide phage library. Unbound phage particles are washed away, bound phage eluted and amplified, and used for repeated rounds of selections.
Enriched binding clones are sequenced. d Yeast surface display: A library of peptides are displayed on the surface of yeast cells and incubated with a
target protein. The target protein is labeled with a fluorescent tag and the cells are sorted based on peptide binding using FACS. Sorted pools are
sequenced. e Yeast-two-hybrid: The binding domain (BD) of a transcription factor is linked to the target protein and the activation domain (AD) of the
same transcription factor is linked to a peptide. If the protein and peptide interact BD and AD are brought together and the transcription factor
reconstituted. This activates the transcription of a reporter gene
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approach should be applicable for the general purpose of
identifying motif-based interactions.
Apart from characterizing binding specificities of puri-
fied proteins, peptide microarrays can be used to identify
targets from cell lysate. Taking such a motif centric ap-
proach, Okada and co-workers identified domains binding
to proline rich peptides by synthesizing a peptide array,
exposing it to cell lysate, cross-linking and identification
of binding proteins through mass spectrometry. Thus,
given a set of motifs, it is possible to identify proteins rec-
ognizing the given sequences [40].
Taken together, peptide arrays are useful tools for the
identification and characterization of motifs-based inter-
actions and are suitable for addressing interactions that
rely on PTMs.
Protein arrays
In protein microarrays (Fig. 1b), proteins of interest are
immobilized on a surface and then probed for binding to a
labeled protein or peptide [41]. Proteins can be prepared by
over-expression and high-throughput purification followed
by spotting on the surface, or be obtained by cell-free
protein expression systems [42, 43]. Proteomic microar-
rays allow the investigation of protein-protein interac-
tions on a global scale [44, 45]. Protein microarrays
have for example been used to elucidate the peptide
binding specificities of the WW domain family [15]. Po-
tential WW binding sites in the human proteome were
identified by scanning the proteome using previously
known motifs. Representative peptides were synthesized
and their binding towards the WW domains tested
through a quantitative ELISA-like binding assay. In an-
other study, protein microarrays of SH2 domains and
phosphotyrosine-binding (PTB) domains were used to
explore their phosphorylation dependent interactions
with 61 peptides representing tyrosine phosphorylation
sites on the ErbB receptors [20]. Additionally, the spec-
ificities of PDZ domains were analyzed through protein
microarrays paired with quantitative fluorescence
polarization [13]. Protein arrays are thus useful tools
for the comparative analysis of binding specificities of
peptide binding modules. Among the advantages are
the low sample consumption and the possibility to
study interactions relying on PTMs. The method can
further be used to obtain quantitative information on
binding affinities. Among the disadvantages are the
labor intense set-up and the requirement for rather
high affinity interactions (KD <50 μM) [46].
Display methods
Peptide phage display
Peptide phage display is a powerful tool for the analysis
of binding specificities of peptide binding domains [47].
Phages are viruses that infect bacteria. A link between
the genotype and phenotype of the phage is provided
by inserting DNA inside of the phage that encode for
peptides which are displayed on the phage surface.
Binding clones are enriched through selections against
immobilized bait proteins and are then subjected to se-
quence analysis (Fig. 1c). There are various phage display
systems, with the most commonly used being the p3 or
p8 protein of the filamentous M13 phage or the minor
coat protein 10B of the lytic T7 phage, as reviewed else-
where [47]. The display can be either monovalent or
multivalent, the former being preferred for capturing
stronger interactions and the latter more suited for the
identification of weaker interactions due to the avidity
of the displayed peptides. The main strength of the
method is that it allows the construction of highly di-
verse peptide libraries (1010) at a rather low cost. In a
typical combinatorial peptide phage display experiment,
libraries display randomized peptide sequences. The
bottleneck has traditionally been the sequencing of
binding clones. Today, next-generation sequencing brings
down the cost of sequencing and the labor, which has
opened new possibilities to exploit the potential of phage
Table 2 Overview of discussed methods for identification and characterization of motif based interactions
Method Peptide library size Pros Cons
Combinatorial phage display 1010 Library size No PTMs, various biases
ProP-PD 104–-106 Unbiased No PTMs
Yeast surface display 108 Some PTMs, unbiased Limited library size
Peptide array 102 – 103 PTMs, semi-quantitative Limited coverage
Biased library
Cost of materials
High-density array 105 – 106 Coverage Cost of materials
Protein microarray 10–100 s Semi-quantitative Protein stability
Labor intense set-up
Y2H 106 Low tech No PTMs
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display and to gain control over the phage library compo-
sitions [48].
Peptide phage display has been used to characterize
the binding specificities of various domain families. For
example, the binding specificities of the yeast SH3 do-
mains were elucidated in 2002, and the results were
paired with computational predictions and with a Y2H
derived protein-protein interaction network [17]. More
than 10 years later, Xin et al. profiled the binding prefer-
ences of 36 SH3 domains of Caenorhabditis elegans [16],
which revealed that the binding preferences were largely
conserved between yeast and worm. Also the PDZ do-
mains have been profiled through phage display. Tonikian
et al. performed a large-scale characterization of PDZ
binding specificities for 54 human and 28 worm PDZ do-
mains [14], which allowed for an extended classification of
their binding specificities. This information was later used
to identify subspecificities among PDZ domains [49] and
was paired with peptide array data [13] to construct a hu-
man PDZ domain-ligand interaction network [50].
Combinatorial phage display selections are useful for the
identification of high affinity binders and the generation of
consensus motifs. However, the displayed peptides may
have little to do with biologically relevant targets. A study
by Luck et al. highlighted that several of the consensus
motifs for PDZ domains derived from combinatorial
phage display are overly hydrophobic (i.e. tryptophan
rich), which compromises the predictions [51]. Different
attempts have been made to create phage libraries that
display peptides representing parts of the human prote-
ome, among them cDNA display and open reading frame
display [47, 52]. These experiments have typically suffered
from low library quality. A recent addition is the prote-
omic peptide phage display (ProP-PD) where phage librar-
ies are designed to display regions of a target proteome
[53, 54]. This method combines microarray synthesis of
highly defined oligonucleotide libraries and next-
generation sequencing. In 2011, Larman and co-workers
created a T7 phage library that displays 36-mer peptides
covering the human proteome [54]. More recently, this
was followed by a study where M13 phage libraries were
created to display the C-terminal peptides of human or
viral proteins [53]. The C-terminal ProP-PD libraries were
validated against a set of PDZ domains and it efficiently
identified binders of potential biological relevance. ProP-
PD directly identifies the binding motifs and the host pro-
teins, thus obviating the need for predictions.
Phage display is an efficient approach for the deter-
mination of peptide binding specificities, which in case
of ProP-PD provides direct information on binding
sites in target proteins. Among the main benefits is the
possibility to create highly diverse phage libraries and
the fact that once a library has been created, it can be
used over and over again. The method is suited for
unbiased discovery of binding motifs, as no information
is required beforehand for designing the phage display
libraries. Phage display can be performed in high
throughput. In such experiments, protein expression,
purification and phage selections are performed in 96-well
plates and the retained phage pools are analyzed by next-
generation sequencing [55]. The limiting factors for these
experiments are the availability of expression constructs,
data analysis and the downstream validations. The main
limitation of the technique is that it is not suited for cap-
turing interactions that rely on PTMs.
Yeast surface display
Yeast surface display was developed nearly 20 years ago
as a tool for in vitro evolution of proteins [56]. However,
the technique can also be used for identification of
protein-protein interactions and epitope mapping of
antibodies. Similar to phage display, there is a direct link
between the genotype and the phenotype [57–60]. Each
yeast cell carries plasmid DNA that codes for a peptide
that is displayed on the yeast cell surface. Typically, the
Saccharomyces cerevisiae–Aga2p system is used, where
peptides are displayed as fusions with the Aga2p subunit
of the mating protein a-agglutinin (Fig. 1d). Aga2p is
linked to the Aga1p subunit, via two disulfide bonds,
which is anchored to the cell surface. Up to 50,000 cop-
ies of the peptide are displayed on a single cell. The cells
are incubated with labeled protein and sorted based on
binding to the protein using fluorescence-activated cell
sorting (FACS) or magnetic-activated cell sorting (MACS).
The sorted pools are thereafter sequenced. Signal inten-
sities resulting from binding can be normalized against
expression levels of the displayed peptide by concurrently
tagging the peptide with a fluorescent tag.
Similar to phage display, next-generation sequencing
has opened new possibilities to obtain comprehensive
information on binding clones. The combination was for
example used to identify unique major histocompability
complex peptides that are recognized by T cell receptors
[61]. It has also been used to identify peptides that bind
to either Mcl-1 or Bcl-xL selectively, or to both with
high affinity, by screening a library of randomized BH3
peptides [62]. An advantage of yeast surface display is
the possibility to obtain information on non-binding
clones. Another significant advantage is that yeast is
eukaryotic and the system has some levels of PTMs. The
main limitation with yeast surface display is the through-
put, which is 100–1000 magnitudes lower than that of
phage display.
Y2H
Y2H was first reported in 1989 [63]. It relies on the split-
ting of a DNA binding domain and an activation domain
of a transcription factor that are linked to a prey or a
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bait protein. If the bait and prey proteins interact, the
two domains of the transcription factor are brought to-
gether and the reconstituted transcription factor activate
the transcription of reporter genes (Fig. 1e). The assay
can be carried out against one prey at a time, or against
libraries of prey proteins/peptides. Y2H is currently
providing a massive amount of data on protein-protein
interactions through the systematic efforts of Vidal and
co-workers [3]. The method is in theory capable of cap-
turing interactions relying on motif based interactions,
but is in practice largely failing to identify these kinds
of interactions [64]. Furthermore, Y2H does typically
not provide information on the motifs involved in the
identified binary interactions. For example, a large scale
Y2H analysis of PDZ domains suggested that many
PDZ domains do not rely on a free C-terminal region
for binding, however the study did not identify the in-
ternal binding motifs [65]. Despite these issues, there
are several successful cases of motif profiling through
Y2H, such as the successful identification of SUMO inter-
acting motifs for SUMO1 and SUMO2 [66]. In case of
PDZ domains, Belotti and co-workers constructed an
array for Y2H screening that contain 96 % of the human
PDZ domains, and validated it against a select set of C-
terminal preys, such as the E6 oncoviral protein and a set
of protein kinases [67]. The interactions were further con-
firmed through mass spectrometry.
Y2H can also be used for characterization of peptide
binding motifs by screening random peptide libraries
[68]. For example, specificities of five PDZ domains were
analyzed by screening of a candidate ligand library using
a Y2H mating array [69]. Furthermore, the PDZ proteins
PDZK1 and LNX were analyzed through Y2H screening
against random peptide libraries [70, 71]. Similarly, the
binding preferences for internal PDZ binding motifs was
profiled by screening of 24 PDZ domains against a
nearly random octapeptide Y2H library [72]. Thus, Y2H
can be adopted for domain-motif interaction screening.
The main issues with the method are a high percentage
of false positives and false negatives read-outs. A par-
ticular issue is that the assay requires that proteins can
be translocated to the nucleus. Although not reviewed
here, there are other split-protein systems that may iden-
tify motif-based interactions [73, 74].
Validations of domain-motif interactions
With the development of high-throughput methods for
identification of domain-motif interactions there is a
need for high-throughput methods for affinity determin-
ation. In addition, if the aim is to identify biologically
relevant domain-motif interactions, cell based valida-
tions are crucial. Both of these downstream validations
may create bottlenecks. Typical methods for affinity de-
terminations such as surface plasmon resonance and
ITC provide high quality information, but have limited
throughputs. To tackle the issue, various studies have
reported methods for high-throughput measurements
of protein-peptide interactions. A protocol for high-
throughput affinity determinations using a protein
microarray and fluorescently labeled synthetic peptides
was published by Kaushansky et al. [46]. Moreover, a
large-scale fluorescence polarization (FP) methodology
using synthetic phosphopeptides was reported for affin-
ity determinations of interactions involving the ErbB
receptor phosphosites [19] and Reich et al. described
SORTCERY, which is a method for ranking hundreds of
yeast-displayed peptides according to their affinities for
a target interaction partner [75]. The procedure in-
volves fluorescence-activated cell sorting of a library,
next-generation sequencing of sorted pools and compu-
tational analysis.
A recent addition is the high-throughput holdup assay
[76]. The method is developed for affinity determina-
tions of domain-motif interactions and can measure up
to 1,000 binding affinities per day. Essentially, extracts of
overexpressed proteins are incubated with resin satu-
rated with ligands. This is followed by filtration where
bound protein stays on the resin, while unbound protein
will pass through the filter. The amount of protein in
the flow-through are analyzed by microfluidic capillary
electrophoresis and is inversely correlated to the affinity
of the interactions. In the proof-of-principle experi-
ments, the authors benchmarked the method against
210 PDZ-peptide interactions of known affinities.
If aiming for the identification of interactions of poten-
tial biological relevance, it is crucial to confirm interac-
tions in the context of the full-length proteins. Such
validations can, for example, be made through the high-
throughput luminescence-based mammalian interactome
mapping (LUMIER) assays [77, 78], the mammalian
protein-protein interaction trap (MAPPIT) [79], or yellow
fluorescence protein-fragment complementation assay
[80]. As reviewed recently, there is a growing number of
approaches for studying and validating protein-protein in-
teractions in cell signaling networks [81].
Computational approaches
Complementing the experimental approaches, different
computational approaches have been developed for the
identification of motifs, such as SLiMFinder [82], DoR-
eMi [83], and MotifHound [84]. To identify motifs in a
given sequence, a combination of sequence properties is
typically used such as i) a disorder propensity as motifs
are enriched in disordered regions [85], ii) sequence
conservation [86] and iii) a tendency to occur in func-
tionally related proteins [82]. For example, a recent
study on mitosis related proteins identified a new motif
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(Fx[ILV][FHY]x[DE]) termed the ABBA motif in the A
type cyclins BUBR1, BUB1 and Acm1 [87].
While most approaches focus on the disorder property,
Stein et al. took a structure based approach focusing on
the fact that most motifs that are found in disordered
regions will take defined structure(s) upon binding [88].
By scanning through the available protein complexes in
the PDB, they discovered unnoticed peptide-based in-
teractions and reported a list of novel peptide binding
domains together with their recognition motifs. Follow-
ing a structure- and data-based approach, De Bartolo
and co-workers performed a genome-wide prediction
of peptides binding to the human prosurvival Bcl-2
proteins. Predicted interactions were tested through
SPOT arrays and in solution affinity measurements re-
vealed affinities in the 1–500 nM KD range [89].
Recently, Chen et al. performed a genome-wide predic-
tion of motif-mediated interactions by taking advantage of
the known motifs in the ELM database, analyzing struc-
tures of domain-motif complexes and using non-structural
information such as the gene ontology similarities and
phylogenetic profile similarities [90]. They provided a list
of 79,000 new predicted domain-motif interactions, al-
though without experimental validation. In the future, it
will be interesting to follow how computational analysis
and experiments together map out motifs in various
proteomes.
Conclusions
There is a plethora of experimental methods for the
identification and characterization of domain-motif in-
teractions (Table 2). Each method has its pros and cons,
but together they provide complementary data. From
our literature review it is clear that most of these
methods have been developed for, and applied to, a limit
set of ubiquitous domain families such as PDZ, WW,
SH2 and SH3 domains, leaving many of the peptide
binding domain families largely uncharted.
Interactions that rely on PTMs such as phosphorylation
or acetylation are a challenge for most methods and there
is a need for method development to allow for efficient
identification of such interactions. Other challenges relate
to fact that scaffold proteins often are composed of arrays
of domains. Although information on the binding specific-
ities of individual domains may be available, it does not
necessary reflect the specificity of the domains in the con-
text of the full-length proteins. In addition, connected do-
mains of a bait protein might bind to linked motifs in a
target protein, which may increase the apparent affinity
and enhance the specificity of the interactions [91, 92].
Thus, dedicated approaches should be developed to ac-
count for such scenarios.
Nevertheless, by taking advantage of methods such as
high-density peptide microarrays and proteomic display
methods, and focusing the efforts on less explored pep-
tide binding domain families it should be feasible to
largely expand the knowledge on the binding motifs in
the proteomes within the next ten years. By combining
the finding from such efforts with the results of high-
throughput Y2H and AP-MS we will obtain detailed maps
of protein-protein interaction networks with assigned bind-
ing sites.
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